Multi-platform Approach for Microbial Biomarker Identification Using Borrelia burgdorferi as a Model

Kathryn J. Pflughoeft, Michael Mash, Nicole R. Hasenkampf, Mary B. Jacobs, Amanda C. Tardo, Dewey Magee, Lusheng Song, Joshua LaBaer, Mario T. Philipp, Monica E. Embers, David P. AuCoin

Research output: Contribution to journalArticle

Abstract

The identification of microbial biomarkers is critical for the diagnosis of a disease early during infection. However, the identification of reliable biomarkers is often hampered by a low concentration of microbes or biomarkers within host fluids or tissues. We have outlined a multi-platform strategy to assess microbial biomarkers that can be consistently detected in host samples, using Borrelia burgdorferi, the causative agent of Lyme disease, as an example. Key aspects of the strategy include the selection of a macaque model of human disease, in vivo Microbial Antigen Discovery (InMAD), and proteomic methods that include microbial biomarker enrichment within samples to identify secreted proteins circulating during infection. Using the described strategy, we have identified 6 biomarkers from multiple samples. In addition, the temporal antibody response to select bacterial antigens was mapped. By integrating biomarkers identified from early infection with temporal patterns of expression, the described platform allows for the data driven selection of diagnostic targets.

Original languageEnglish (US)
Article number179
JournalFrontiers in Cellular and Infection Microbiology
Volume9
Issue numberJUN
DOIs
StatePublished - Jan 1 2019

Fingerprint

Borrelia burgdorferi
Biomarkers
Infection
Bacterial Antigens
Lyme Disease
Macaca
Proteomics
Antibody Formation
Antigens

Keywords

  • Antibody response
  • Borrelia burgdorferi
  • Early diagnostic
  • Lyme disease
  • Microbial biomarker discovery

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Multi-platform Approach for Microbial Biomarker Identification Using Borrelia burgdorferi as a Model. / Pflughoeft, Kathryn J.; Mash, Michael; Hasenkampf, Nicole R.; Jacobs, Mary B.; Tardo, Amanda C.; Magee, Dewey; Song, Lusheng; LaBaer, Joshua; Philipp, Mario T.; Embers, Monica E.; AuCoin, David P.

In: Frontiers in Cellular and Infection Microbiology, Vol. 9, No. JUN, 179, 01.01.2019.

Research output: Contribution to journalArticle

Pflughoeft, KJ, Mash, M, Hasenkampf, NR, Jacobs, MB, Tardo, AC, Magee, D, Song, L, LaBaer, J, Philipp, MT, Embers, ME & AuCoin, DP 2019, 'Multi-platform Approach for Microbial Biomarker Identification Using Borrelia burgdorferi as a Model', Frontiers in Cellular and Infection Microbiology, vol. 9, no. JUN, 179. https://doi.org/10.3389/fcimb.2019.00179
Pflughoeft, Kathryn J. ; Mash, Michael ; Hasenkampf, Nicole R. ; Jacobs, Mary B. ; Tardo, Amanda C. ; Magee, Dewey ; Song, Lusheng ; LaBaer, Joshua ; Philipp, Mario T. ; Embers, Monica E. ; AuCoin, David P. / Multi-platform Approach for Microbial Biomarker Identification Using Borrelia burgdorferi as a Model. In: Frontiers in Cellular and Infection Microbiology. 2019 ; Vol. 9, No. JUN.
@article{dc807fa0a84f422fac1d75b3ce7d4612,
title = "Multi-platform Approach for Microbial Biomarker Identification Using Borrelia burgdorferi as a Model",
abstract = "The identification of microbial biomarkers is critical for the diagnosis of a disease early during infection. However, the identification of reliable biomarkers is often hampered by a low concentration of microbes or biomarkers within host fluids or tissues. We have outlined a multi-platform strategy to assess microbial biomarkers that can be consistently detected in host samples, using Borrelia burgdorferi, the causative agent of Lyme disease, as an example. Key aspects of the strategy include the selection of a macaque model of human disease, in vivo Microbial Antigen Discovery (InMAD), and proteomic methods that include microbial biomarker enrichment within samples to identify secreted proteins circulating during infection. Using the described strategy, we have identified 6 biomarkers from multiple samples. In addition, the temporal antibody response to select bacterial antigens was mapped. By integrating biomarkers identified from early infection with temporal patterns of expression, the described platform allows for the data driven selection of diagnostic targets.",
keywords = "Antibody response, Borrelia burgdorferi, Early diagnostic, Lyme disease, Microbial biomarker discovery",
author = "Pflughoeft, {Kathryn J.} and Michael Mash and Hasenkampf, {Nicole R.} and Jacobs, {Mary B.} and Tardo, {Amanda C.} and Dewey Magee and Lusheng Song and Joshua LaBaer and Philipp, {Mario T.} and Embers, {Monica E.} and AuCoin, {David P.}",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fcimb.2019.00179",
language = "English (US)",
volume = "9",
journal = "Frontiers in cellular and infection microbiology",
issn = "2235-2988",
publisher = "Frontiers Media S. A.",
number = "JUN",

}

TY - JOUR

T1 - Multi-platform Approach for Microbial Biomarker Identification Using Borrelia burgdorferi as a Model

AU - Pflughoeft, Kathryn J.

AU - Mash, Michael

AU - Hasenkampf, Nicole R.

AU - Jacobs, Mary B.

AU - Tardo, Amanda C.

AU - Magee, Dewey

AU - Song, Lusheng

AU - LaBaer, Joshua

AU - Philipp, Mario T.

AU - Embers, Monica E.

AU - AuCoin, David P.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The identification of microbial biomarkers is critical for the diagnosis of a disease early during infection. However, the identification of reliable biomarkers is often hampered by a low concentration of microbes or biomarkers within host fluids or tissues. We have outlined a multi-platform strategy to assess microbial biomarkers that can be consistently detected in host samples, using Borrelia burgdorferi, the causative agent of Lyme disease, as an example. Key aspects of the strategy include the selection of a macaque model of human disease, in vivo Microbial Antigen Discovery (InMAD), and proteomic methods that include microbial biomarker enrichment within samples to identify secreted proteins circulating during infection. Using the described strategy, we have identified 6 biomarkers from multiple samples. In addition, the temporal antibody response to select bacterial antigens was mapped. By integrating biomarkers identified from early infection with temporal patterns of expression, the described platform allows for the data driven selection of diagnostic targets.

AB - The identification of microbial biomarkers is critical for the diagnosis of a disease early during infection. However, the identification of reliable biomarkers is often hampered by a low concentration of microbes or biomarkers within host fluids or tissues. We have outlined a multi-platform strategy to assess microbial biomarkers that can be consistently detected in host samples, using Borrelia burgdorferi, the causative agent of Lyme disease, as an example. Key aspects of the strategy include the selection of a macaque model of human disease, in vivo Microbial Antigen Discovery (InMAD), and proteomic methods that include microbial biomarker enrichment within samples to identify secreted proteins circulating during infection. Using the described strategy, we have identified 6 biomarkers from multiple samples. In addition, the temporal antibody response to select bacterial antigens was mapped. By integrating biomarkers identified from early infection with temporal patterns of expression, the described platform allows for the data driven selection of diagnostic targets.

KW - Antibody response

KW - Borrelia burgdorferi

KW - Early diagnostic

KW - Lyme disease

KW - Microbial biomarker discovery

UR - http://www.scopus.com/inward/record.url?scp=85068913506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068913506&partnerID=8YFLogxK

U2 - 10.3389/fcimb.2019.00179

DO - 10.3389/fcimb.2019.00179

M3 - Article

VL - 9

JO - Frontiers in cellular and infection microbiology

JF - Frontiers in cellular and infection microbiology

SN - 2235-2988

IS - JUN

M1 - 179

ER -